Autobio Diagnostics Co.,Ltd. (603658.SH) has announced that the company and its wholly-owned subsidiary, Autobio Instruments (Zhengzhou) Co., Ltd., recently received medical device registration certificates issued by the National Medical Products Administration and the Henan Provincial Medical Products Administration. A total of four products have obtained these registrations. They are: the fully automated chemiluminescence immunoassay analyzer (models: AutoLumo A6900, AutoLumo A9000, AutoLumo A9600), the Epstein-Barr virus capsid antigen IgM antibody detection kit (magnetic particle chemiluminescence method), the Mycoplasma pneumoniae nucleic acid and drug-resistant mutation site detection kit (PCR-fluorescence probe method), and the Interleukin-17A detection kit (magnetic particle chemiluminescence method).